Organogenesis Holdings (ORGO) Net Margin (2017 - 2026)

Organogenesis Holdings' Net Margin history runs 10 years deep, the most recent figure standing at 150.85% for Q1 2026.

• On a quarterly basis, Net Margin fell 12595.0% year-over-year to 150.85% in Q1 2026; TTM through Mar 2026 was 2.54%, a 191.0% increase from a year earlier, with the FY2025 full-year figure at 4.55%, up 474.0% from the prior year.
• Net Margin retreated to 150.85% in Q1 2026 per ORGO's latest filing, from 18.07% in the prior quarter.
• Across five years, Net Margin topped out at 18.07% in Q4 2025 and bottomed at 150.85% in Q1 2026.
• The 5-year median for Net Margin is 1.45% (2023), against an average of 8.28%.
• Across the five-year window, Net Margin jumped 1343 bps in 2025 and slumped 12595 bps in 2026, its largest moves.
• Year by year, Net Margin stood at 6.48% in 2022, then tumbled by 78 bps to 1.45% in 2023, then jumped by 220 bps to 4.64% in 2024, then soared by 290 bps to 18.07% in 2025, then tumbled by 935 bps to 150.85% in 2026.
• Per Business Quant, the three latest ORGO Net Margin figures stand at 150.85% (Q1 2026), 18.07% (Q4 2025), and 9.63% (Q3 2025).